Genetic Variants and Insulin Release in Type 2 Diabetes
Author Information
Author(s): Hornbak Malene, Banasik Karina, Justesen Johanne M, Krarup Nikolaj T, Sandholt Camilla H, Andersson Åsa, Sandbæk Annelli, Lauritzen Torsten, Pisinger Charlotta, Witte Daniel R, Sørensen Thorkild IA, Pedersen Oluf, Hansen Torben
Primary Institution: Marie Krogh Center for Metabolic Research, University of Copenhagen, Denmark
Hypothesis
The study aimed to investigate whether the variants rs2014355 in ACADS and rs11161510 in ACADM associate with altered insulin release following an oral glucose load or with type 2 diabetes.
Conclusion
The minor C-allele of rs2014355 in ACADS was associated with reduced measures of glucose-stimulated insulin release during an oral glucose tolerance test.
Supporting Evidence
- Carriers of the C-allele of rs2014355 had decreased serum insulin levels at 30 minutes after an oral glucose load.
- The C-allele was associated with reduced incremental area under the insulin curve during an OGTT.
- The C-allele did not associate with type 2 diabetes in the case-control analysis.
Takeaway
People with a specific gene variant may not release as much insulin after eating sugar, which could affect their risk of diabetes.
Methodology
The study used KASPar® PCR SNP genotyping to analyze genetic variants and their associations with insulin release and sensitivity in a large sample of Danish individuals.
Limitations
The study could not find a significant association between the C-allele and the risk of type 2 diabetes, indicating potential limitations in detecting smaller effects.
Participant Demographics
The study included 10,276 Danish individuals, with a focus on middle-aged participants.
Statistical Information
P-Value
0.003
Confidence Interval
(-6.3%;-1.3%)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website